These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 14536082)

  • 1. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.
    Stancheva I; Collins AL; Van den Veyver IB; Zoghbi H; Meehan RR
    Mol Cell; 2003 Aug; 12(2):425-35. PubMed ID: 14536082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation gets SMRT. Functional insights into Rett syndrome.
    Vetter ML
    Dev Cell; 2003 Sep; 5(3):359-60. PubMed ID: 12967552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology. MeCP2 repression goes nonglobal.
    Klose R; Bird A
    Science; 2003 Oct; 302(5646):793-5. PubMed ID: 14593157
    [No Abstract]   [Full Text] [Related]  

  • 4. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rett syndrome: a surprising result of mutation in MECP2.
    Dragich J; Houwink-Manville I; Schanen C
    Hum Mol Genet; 2000 Oct; 9(16):2365-75. PubMed ID: 11005791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of Rett syndrome mutations on human MeCP2.
    Yusufzai TM; Wolffe AP
    Nucleic Acids Res; 2000 Nov; 28(21):4172-9. PubMed ID: 11058114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
    Wan M; Zhao K; Lee SS; Francke U
    Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology of Rett syndrome.
    Akbarian S
    Neuroscientist; 2003 Feb; 9(1):57-63. PubMed ID: 12580340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
    Ballestar E; Yusufzai TM; Wolffe AP
    Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
    Balmer D; Arredondo J; Samaco RC; LaSalle JM
    Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.
    Hansen JC; Ghosh RP; Woodcock CL
    IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
    Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
    Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.
    Fuks F; Hurd PJ; Wolf D; Nan X; Bird AP; Kouzarides T
    J Biol Chem; 2003 Feb; 278(6):4035-40. PubMed ID: 12427740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel protein, Xenopus p20, influences the stability of MeCP2 through direct interaction.
    Carro S; Bergo A; Mengoni M; Bachi A; Badaracco G; Kilstrup-Nielsen C; Landsberger N
    J Biol Chem; 2004 Jun; 279(24):25623-31. PubMed ID: 15056664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.
    Chen WG; Chang Q; Lin Y; Meissner A; West AE; Griffith EC; Jaenisch R; Greenberg ME
    Science; 2003 Oct; 302(5646):885-9. PubMed ID: 14593183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Dragich J; Schanen C; Tamura M
    Brain Dev; 2001 Dec; 23 Suppl 1():S165-73. PubMed ID: 11738866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.
    Chandler SP; Guschin D; Landsberger N; Wolffe AP
    Biochemistry; 1999 Jun; 38(22):7008-18. PubMed ID: 10353812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered methylation pattern of the G6 PD promoter in Rett syndrome.
    Huppke P; Bohlander S; Krämer N; Laccone F; Hanefeld F
    Neuropediatrics; 2002 Apr; 33(2):105-8. PubMed ID: 12075494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation in the gene body influences MeCP2-mediated gene repression.
    Kinde B; Wu DY; Greenberg ME; Gabel HW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.